Literature DB >> 11274459

Analysis of inhibitor binding in influenza virus neuraminidase.

B J Smith1, P M Colman, M Von Itzstein, B Danylec, J N Varghese.   

Abstract

2,3-didehydro-2-deoxy-N:-acetylneuraminic acid (DANA) is a transition state analog inhibitor of influenza virus neuraminidase (NA). Replacement of the hydroxyl at the C9 position in DANA and 4-amino-DANA with an amine group, with the intention of taking advantage of an increased electrostatic interaction with a conserved acidic group in the active site to improve inhibitor binding, significantly reduces the inhibitor activity of both compounds. The three-dimensional X-ray structure of the complexes of these ligands and NA was obtained to 1.4 A resolution and showed that both ligands bind isosterically to DANA. Analysis of the geometry of the ammonium at the C4 position indicates that Glu119 may be neutral when these ligands bind. A computational analysis of the binding energies indicates that the substitution is successful in increasing the energy of interaction; however, the gains that are made are not sufficient to overcome the energy that is required to desolvate that part of the ligand that comes in contact with the protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274459      PMCID: PMC2373964          DOI: 10.1110/ps.41801

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  31 in total

Review 1.  Resistance of influenza viruses to neuraminidase inhibitors--a review.

Authors:  J L McKimm-Breschkin
Journal:  Antiviral Res       Date:  2000-07       Impact factor: 5.970

2.  The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.

Authors:  J N Varghese; J L McKimm-Breschkin; J B Caldwell; A A Kortt; P M Colman
Journal:  Proteins       Date:  1992-11

3.  A new method for the purification of the influenza A virus neuraminidase.

Authors:  J L McKimm-Breschkin; J B Caldwell; R E Guthrie; A A Kortt
Journal:  J Virol Methods       Date:  1991-04       Impact factor: 2.014

4.  A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase.

Authors:  N R Taylor; M von Itzstein
Journal:  J Comput Aided Mol Des       Date:  1996-06       Impact factor: 3.686

5.  Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.

Authors:  V R Atigadda; W J Brouillette; F Duarte; S M Ali; Y S Babu; S Bantia; P Chand; N Chu; J A Montgomery; D A Walsh; E A Sudbeck; J Finley; M Luo; G M Air; G W Laver
Journal:  J Med Chem       Date:  1999-07-01       Impact factor: 7.446

Review 6.  Effectiveness and role of zanamivir in the treatment of influenza infection.

Authors:  C A Silagy; K Campion
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

Review 7.  Zanamivir: a review of its use in influenza.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

Review 8.  'Flu' and structure-based drug design.

Authors:  R C Wade
Journal:  Structure       Date:  1997-09-15       Impact factor: 5.006

9.  Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase.

Authors:  J N Varghese; P W Smith; S L Sollis; T J Blick; A Sahasrabudhe; J L McKimm-Breschkin; P M Colman
Journal:  Structure       Date:  1998-06-15       Impact factor: 5.006

10.  Structures of aromatic inhibitors of influenza virus neuraminidase.

Authors:  M J Jedrzejas; S Singh; W J Brouillette; W G Laver; G M Air; M Luo
Journal:  Biochemistry       Date:  1995-03-14       Impact factor: 3.162

View more
  19 in total

1.  Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.

Authors:  Hui-Ling Yen; Erich Hoffmann; Garry Taylor; Christoph Scholtissek; Arnold S Monto; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Thermodynamic basis for promiscuity and selectivity in protein-protein interactions: PDZ domains, a case study.

Authors:  Nathalie Basdevant; Harel Weinstein; Marco Ceruso
Journal:  J Am Chem Soc       Date:  2006-10-04       Impact factor: 15.419

3.  Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study.

Authors:  Zhiwei Yang; Gang Yang; Lijun Zhou
Journal:  J Comput Aided Mol Des       Date:  2013-11-12       Impact factor: 3.686

4.  Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.

Authors:  William J Allen; Brian C Fochtman; Trent E Balius; Robert C Rizzo
Journal:  J Comput Chem       Date:  2017-09-22       Impact factor: 3.376

5.  DiSCaMB: a software library for aspherical atom model X-ray scattering factor calculations with CPUs and GPUs.

Authors:  Michał L Chodkiewicz; Szymon Migacz; Witold Rudnicki; Anna Makal; Jarosław A Kalinowski; Nigel W Moriarty; Ralf W Grosse-Kunstleve; Pavel V Afonine; Paul D Adams; Paulina Maria Dominiak
Journal:  J Appl Crystallogr       Date:  2018-02-01       Impact factor: 3.304

6.  Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase.

Authors:  Maretta C Mann; Tasneem Islam; Jeffrey C Dyason; Pas Florio; Carolyn J Trower; Robin J Thomson; Mark von Itzstein
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

7.  On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9.

Authors:  Ornjira Aruksakunwong; Maturos Malaisree; Panita Decha; Pornthep Sompornpisut; Vudhichai Parasuk; Somsak Pianwanit; Supot Hannongbua
Journal:  Biophys J       Date:  2006-11-03       Impact factor: 4.033

8.  DOCK 6: Impact of new features and current docking performance.

Authors:  William J Allen; Trent E Balius; Sudipto Mukherjee; Scott R Brozell; Demetri T Moustakas; P Therese Lang; David A Case; Irwin D Kuntz; Robert C Rizzo
Journal:  J Comput Chem       Date:  2015-06-05       Impact factor: 3.376

9.  Combining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibition.

Authors:  Paulina M Dominiak; Anatoliy Volkov; Adam P Dominiak; Katarzyna N Jarzembska; Philip Coppens
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-04-18

10.  Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase.

Authors:  Louise Birch; Christopher W Murray; Michael J Hartshorn; Ian J Tickle; Marcel L Verdonk
Journal:  J Comput Aided Mol Des       Date:  2002-12       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.